Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma

Claudia A Benavente1, Michael A Dyer

  • 1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, 38105-3678, USA.

Insights

Retinoblastoma, a pediatric retinal cancer, arises from RB1 gene inactivation. Mouse models are crucial for studying tumor development and testing treatments after Rb loss.

Area of Science:

  • Oncology
  • Genetics
  • Ophthalmology

Background:

  • Retinoblastoma is a rare pediatric cancer originating in the developing retina.
  • It is characterized by the biallelic inactivation of the RB1 gene.
  • Understanding retinoblastoma tumorigenesis is critical for developing effective therapies.

Purpose of the Study:

  • To describe genetically engineered mouse models of retinoblastoma.
  • To detail orthotopic human xenograft models for retinoblastoma research.
  • To discuss the advantages and disadvantages of various retinoblastoma models.

Main Methods:

  • Review of genetically engineered mouse models.
  • Description of orthotopic xenograft model development.
  • Comparative analysis of model systems.

Main Results:

  • Genetically engineered mouse models recapitulate retinoblastoma development following Rb loss.
  • Orthotopic xenografts allow for the study of human retinoblastoma in vivo.
  • Each model offers distinct advantages for preclinical research.

Conclusions:

  • Mouse and xenograft models are invaluable tools for retinoblastoma research.
  • These models facilitate the study of tumorigenesis and preclinical therapeutic evaluation.
  • Selecting the appropriate model is essential for advancing retinoblastoma treatment strategies.